Status:
TERMINATED
Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Hemorrhoids
Anal Fissures
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To demonstrate that lactulose acts as a stool softener, relieving the pain at defecation, improving the number of defecations and regulating the colonic transit time in patients suffering of hemorrhoi...
Eligibility Criteria
Inclusion
- Patients suffering from symptomatic hemorrhoids, or symptomatic anal fissure.
Exclusion
- Patients suffering from malignant tumor in the intestine or the anal-rectal region, irritable colon, intestine inflammatory disease.
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00160290
Start Date
March 1 2002
End Date
June 1 2006
Last Update
May 6 2008
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 2
Barcelona, Spain
2
Site 6
Granada, Spain
3
Site 5
Huesca, Spain
4
Site 7
Oviedo, Spain